Beijing Leadman Biochemistry Co Ltd Strategic Asset Allocation Index
Beijing Leadman Biochemistry Co Ltd strategic asset allocation index. Beijing Leadman Biochemistry Co Ltd (300289) has a Strategic Asset Allocation Index of 24.5% as of June 2023. Strategic assets (PP&E of CN¥441.15 Million plus long-term investments of CN¥-) total CN¥441.15 Million, measured against net assets of CN¥1.80 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300289 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Beijing Leadman Biochemistry Co Ltd (2008–2021)
Strategic asset allocation index of Beijing Leadman Biochemistry Co Ltd from 2008 to 2021. This chart shows how Beijing Leadman Biochemistry Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 24.5%, representing strategic assets of CN¥441.15 Million against net assets of CN¥1.80 Billion CNY. Check Beijing Leadman Biochemistry Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Beijing Leadman Biochemistry Co Ltd Strategic Asset Allocation Index by Year (2008–2021)
Beijing Leadman Biochemistry Co Ltd strategic asset allocation index by year from 2008 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Leadman Biochemistry Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Beijing Leadman Biochemistry Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 24.0% | CN¥474.96 Million | CN¥474.96 Million | CN¥- | CN¥1.98 Billion | ▼ -17.8 pp |
| 2020 | 41.8% | CN¥575.94 Million | CN¥575.94 Million | CN¥- | CN¥1.38 Billion | ▲ +1.2 pp |
| 2019 | 40.6% | CN¥588.51 Million | CN¥588.51 Million | CN¥- | CN¥1.45 Billion | ▼ -1.5 pp |
| 2018 | 42.1% | CN¥604.80 Million | CN¥604.80 Million | CN¥- | CN¥1.44 Billion | ▼ -1.5 pp |
| 2017 | 43.6% | CN¥620.91 Million | CN¥620.91 Million | CN¥- | CN¥1.43 Billion | ▼ -5.0 pp |
| 2016 | 48.6% | CN¥649.50 Million | CN¥649.50 Million | CN¥- | CN¥1.34 Billion | ▼ -4.8 pp |
| 2015 | 53.4% | CN¥672.96 Million | CN¥672.96 Million | CN¥- | CN¥1.26 Billion | ▼ -9.9 pp |
| 2014 | 63.3% | CN¥692.14 Million | CN¥692.14 Million | CN¥- | CN¥1.09 Billion | ▼ -19.3 pp |
| 2013 | 82.7% | CN¥703.61 Million | CN¥703.61 Million | CN¥- | CN¥851.12 Million | ▲ +13.4 pp |
| 2012 | 69.3% | CN¥527.34 Million | CN¥527.34 Million | CN¥- | CN¥761.02 Million | ▼ -20.2 pp |
| 2011 | 89.5% | CN¥197.56 Million | CN¥197.56 Million | CN¥- | CN¥220.77 Million | ▲ +31.7 pp |
| 2010 | 57.8% | CN¥92.24 Million | CN¥92.24 Million | CN¥- | CN¥159.72 Million | ▲ +15.2 pp |
| 2009 | 42.6% | CN¥44.85 Million | CN¥44.85 Million | CN¥- | CN¥105.32 Million | ▼ -5.0 pp |
| 2008 | 47.6% | CN¥39.93 Million | CN¥39.93 Million | CN¥- | CN¥83.90 Million | — |